228 related articles for article (PubMed ID: 33141586)
1. Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.
Sturm T; Sautter B; Wörner TP; Stevanović S; Rammensee HG; Planz O; Heck AJR; Aebersold R
J Proteome Res; 2021 Jan; 20(1):289-304. PubMed ID: 33141586
[TBL] [Abstract][Full Text] [Related]
2. Critical Review of Existing MHC I Immunopeptidome Isolation Methods.
Kuznetsov A; Voronina A; Govorun V; Arapidi G
Molecules; 2020 Nov; 25(22):. PubMed ID: 33228004
[TBL] [Abstract][Full Text] [Related]
3. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.
Haque MA; Hawes JW; Blum JS
J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711
[TBL] [Abstract][Full Text] [Related]
4. Purification and Identification of Naturally Presented MHC Class I and II Ligands.
Nelde A; Kowalewski DJ; Stevanović S
Methods Mol Biol; 2019; 1988():123-136. PubMed ID: 31147937
[TBL] [Abstract][Full Text] [Related]
5. Solving an MHC allele-specific bias in the reported immunopeptidome.
Klatt MG; Mack KN; Bai Y; Aretz ZEH; Nathan LI; Mun SS; Dao T; Scheinberg DA
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32897882
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the MHC I Immunopeptidome Repertoire of B-Cell Lymphoblasts Using Two Isolation Methods.
Lanoix J; Durette C; Courcelles M; Cossette É; Comtois-Marotte S; Hardy MP; Côté C; Perreault C; Thibault P
Proteomics; 2018 Jun; 18(12):e1700251. PubMed ID: 29508533
[TBL] [Abstract][Full Text] [Related]
7. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of MHC ligands in clinical material by immunoaffinity-mass spectrometry.
Kasuga K
Methods Mol Biol; 2013; 1023():203-18. PubMed ID: 23765629
[TBL] [Abstract][Full Text] [Related]
9. Natural Spleen Cell Ligandome in Transporter Antigen Processing-Deficient Mice.
Lorente E; Palomo C; Barnea E; Mir C; Del Val M; Admon A; López D
J Proteome Res; 2019 Sep; 18(9):3512-3520. PubMed ID: 31361958
[TBL] [Abstract][Full Text] [Related]
10. PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification.
Feola S; Haapala M; Peltonen K; Capasso C; Martins B; Antignani G; Federico A; Pietiäinen V; Chiaro J; Feodoroff M; Russo S; Rannikko A; Fusciello M; Koskela S; Partanen J; Hamdan F; Tähkä SM; Ylösmäki E; Greco D; Grönholm M; Kekarainen T; Eshaghi M; Gurvich OL; Ylä-Herttuala S; M Branca RM; Lehtiö J; Sikanen TM; Cerullo V
ACS Nano; 2021 Oct; 15(10):15992-16010. PubMed ID: 34605646
[TBL] [Abstract][Full Text] [Related]
11. Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.
Gebreselassie D; Spiegel H; Vukmanovic S
Hum Immunol; 2006 Nov; 67(11):894-906. PubMed ID: 17145369
[TBL] [Abstract][Full Text] [Related]
12. Contribution of mass spectrometry-based proteomics to immunology.
Hillen N; Stevanovic S
Expert Rev Proteomics; 2006 Dec; 3(6):653-64. PubMed ID: 17181480
[TBL] [Abstract][Full Text] [Related]
13. Cell Surface MHC Class I Expression Is Limited by the Availability of Peptide-Receptive "Empty" Molecules Rather than by the Supply of Peptide Ligands.
Komov L; Kadosh DM; Barnea E; Milner E; Hendler A; Admon A
Proteomics; 2018 Jun; 18(12):e1700248. PubMed ID: 29707912
[TBL] [Abstract][Full Text] [Related]
14. Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity.
Khilko SN; Corr M; Boyd LF; Lees A; Inman JK; Margulies DH
J Biol Chem; 1993 Jul; 268(21):15425-34. PubMed ID: 8393442
[TBL] [Abstract][Full Text] [Related]
15. Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis.
Sirois I; Isabelle M; Duquette JD; Saab F; Caron E
J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723952
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
Appella E; Padlan EA; Hunt DF
EXS; 1995; 73():105-19. PubMed ID: 7579970
[TBL] [Abstract][Full Text] [Related]
17. High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform.
Bruno PM; Timms RT; Abdelfattah NS; Leng Y; Lelis FJN; Wesemann DR; Yu XG; Elledge SJ
Nat Biotechnol; 2023 Jul; 41(7):980-992. PubMed ID: 36593401
[TBL] [Abstract][Full Text] [Related]
18. An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments.
Klatt MG; Aretz ZEH; Curcio M; Gejman RS; Jones HF; Scheinberg DA
J Proteomics; 2020 Sep; 228():103921. PubMed ID: 32758705
[TBL] [Abstract][Full Text] [Related]
19. Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.
Jappe EC; Kringelum J; Trolle T; Nielsen M
Immunology; 2018 Jul; 154(3):407-417. PubMed ID: 29446062
[TBL] [Abstract][Full Text] [Related]
20. Isolation of HLA Bound Peptides by Immunoaffinity Capture and Identification by Mass Spectrometry.
Pandey K; Ramarathinam SH; Purcell AW
Curr Protoc; 2021 Mar; 1(3):e92. PubMed ID: 33769717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
